Source: Virtual Congress 2020 – Treatments and biomarkers for lung allograft function and outcome
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Lebel-Shostak (Petah-Tikva, Israel), B. Pertzov (Petah-Tikva, Israel), O. Grossberger (Petah-Tikva, Israel), D. Rosengarten (Petah-Tikva, Israel), D. Shitenberg (Petah-Tikva, Israel), M. Heshing (Petah-Tikva, Israel), S. Amor (Petah-Tikva, Israel), M. Kramer (Petah-Tikva, Israel). The use of mTOR inhibitors is associated with improved survival in lung transplant recipients. 4724

Member's Comments

No comment yet.

Related content which might interest you:

• Influenza vaccination: protecting the most vulnerable
• The impact of anti-IgE treatment on the airway microbiome in asthma.
• Quality Improvement in a Sleep Clinic: To increase the capacity and reduce the time to treatment for patients with Obstructive Sleep Apnoea